Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma: HELP
Articles by Robert Separović
Based on 2 articles published since 2008
||||

Between 2008 and 2019, Robert Šeparović wrote the following 2 articles about Melanoma.
 
+ Citations + Abstracts
1 Guideline [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer]. 2016

Herceg, Davorin / Jakopović, Marko / Plavetić, Natalija Dedić / Samaržija, Miroslav / Čučević, Branka / Mijatović, Davor / Nikolić, Igor / Trivanović, Dragan / Šeparović, Robert / Vrbanec, Damir. · ·Lijec Vjesn · Pubmed #30148587.

ABSTRACT: Treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not being based on prospective studies, yet on the expert’s opinion of a precise oncological center or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures’ algorithm in follow–up of oncological patients after primary treatment, in patients with melanoma, sarcomas, central nerve system tumors and lung cancer.

2 Guideline [CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP OF PATIENTS WITH MELANOMA]. 2016

Herceg, Davorin / Buzina, Daska Stulhofer / Ceović, Romana / Dotlić, Snjezana / Ilić, Ivana / Orehovec, Sanda Smuđ / Herceg, Gordana Horvatić / Mijatović, Davor / Separović, Robert / Silovski, Tajana / Vrbanec, Damir. · ·Lijec Vjesn · Pubmed #27290810.

ABSTRACT: Melanoma in the Western world has an increasing incidence. One of the most important factor for the increase in incidence is sporadic, uncontrolled exposure to the sun. The basis for the treatment of primary melanoma is surgical treatment. Treatment of metastatic disease of melanoma in recent years experienced significant changes. BRAF and MEK inhibitors, immunotherapy with programmed cell-death immune checkpoint inhibitors (anti-PD-1-antibodies) are new options for the treatment of metastatic disease. A mulitidisiplinary team of Croatian Society for Medical Oncology provides recommendations for diagnosis, treatment and follow-up of melanoma primarily driven to the discovery of new drugs and therapeutic options, that change the prognosis of patients with metastatic melanoma.